Wholesalers control slightly more than half U.S. market, Cardinal/Bergen tell FTC.
This article was originally published in The Tan Sheet
Executive Summary
DRUG WHOLESALERS CONTROL SLIGHTLY MORE THAN HALF OF U.S. MARKET, Bergen Brunswig and Cardinal Health point out in a memorandum filed in D.C. federal court March 18 as part of their opposition to the Federal Trade Commission's legal challenge of their proposed merger. Bergen and Cardinal will argue FTC's definition of the marketplace is far too narrow and ignores the powerful market positions held by manufacturers and large, sophisticated buyers.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning